Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic Study of Mifamurtide in Metastatic/Recurrent Osteosarcoma
2012-000615-84Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Sep 2014
- Modality
- Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mifamurtide in osteosarcoma (OS), sponsored by University of Oxford. Started Sep 2014; status: completed.
02
Drugs
mifamurtide
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on 2012-000615-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000615-84.